跳至主要内容
临床试验/NCT00419666
NCT00419666已完成2 期

PK and PD of Calcitriol Following Twice Daily Application of Calcitriol 3 µg/g Ointment Under Conditions of Maximal Use in Adolescents With Plaque Psoriasis

Galderma R&D7 个研究点 分布在 2 个国家目标入组 25 人开始时间: 2006年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
Galderma R&D
入组人数
25
试验地点
7
主要终点
Trough Plasma Levels (Ctrough) of Calcitriol

研究概览

简要总结

This is an open-label, multicenter study to assess the systemic exposure to calcitriol in the adolescent population. Calcitriol 3µg/g ointment (2 mg/cm² per application) is to be applied twice daily to involved skin (10 - 35% BSA involved, excluding face, scalp and intertriginous areas) for 56 days (8 weeks). Full Pharmacokinetic (PK) and Pharmacodynamic (PD) profile will be collected during the first 3 weeks of the study; safety and efficacy data will be collected for the 8 weeks of the treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of chronic plaque psoriasis
  • 10 - 35% BSA of involved skin
  • Age 12 - 17

排除标准

  • Other type of psoriasis (other than plaque)
  • Significant abnormal lab findings
  • Vit D insufficiency

研究组 & 干预措施

Calcitriol 3mcg/g

Experimental

Participants receive calcitriol 3 micrograms per gram (mcg/g) ointment applied topically twice daily for 56 days.

干预措施: Calcitriol 3mcg/g (Drug)

结局指标

主要结局

Trough Plasma Levels (Ctrough) of Calcitriol

时间窗: Day 0 (Baseline), Day 14, Day 21, and Day 56

Trough plasma levels (Ctrough) of calcitriol was reported.

Area Under the Concentration-Time Curve From Pre-Application (T0) Through 12 Hours Post Dosing (AUC [0-12 Hours])

时间窗: 0 (predose) and 12 hours post dose on Day 0 (Baseline), Day 21

The AUC(0-12 hours) that is area under the plasma concentration-time curve from time 0 to 12 hours after dosing was reported.

The Observed Peak Drug Concentration (Cmax) of Calcitriol

时间窗: Day 0 (Baseline), Day 21

Cmax of calcitriol was reported.

Area Under the Concentration-Time Curve From Pre-Application (T0) Through 9 Hours Post Dosing (AUC [0-9 Hours])

时间窗: 0 (predose) and 9 hours post dose on Day 0 (Baseline), Day 21

The AUC(0-9 hours) that is area under the plasma concentration-time curve from time 0 to 9 hours after dosing was reported.

Time at Which Maximum Concentration (Cmax) Occurred (Tmax)

时间窗: Day 0 (Baseline), Day 21

Tmax is the time to reach maximum concentration and was reported for calcitriol.

次要结局

  • Change From Baseline in Effect of Calcitriol Ointment on Calcium (Serum Calcium, Urinary (U) Calcium Random) and Phosphorus Homeostasis up to Day 56(From baseline (Day 0) up to Day 56)
  • Change From Baseline in Effect of Calcitriol Ointment on Calcium (Serum Calcium Albumin Adjusted) Homeostasis up to Day 56(From baseline (Day 0) up to Day 56)
  • Change From Baseline in Effect of Calcitriol Ointment on Calcium (Urinary Calcium/Creatinine Ratio) Homeostasis up to Day 56(From baseline (Day 0) up to Day 56)
  • Number of Participants With Adverse Events(From start of the study to Day 56)

研究者

发起方
Galderma R&D
申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验